Company news
Vitasora Health Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Reinstatement to Official Quotation
December 13, 2023
$6.5m raised for US expansion, $20m commitment secured
December 13, 2023
Voluntary Suspension
November 30, 2023
Response to ASX Query
November 2, 2023
Further USA Customer Base Growth - ShareCafe Presention
September 29, 2023
Early Redemption of Convertible Note - $1.3m Placement
September 18, 2023
Preliminary Final Report
August 31, 2023
Access secure new $900k annual revenues fr RPM/RTM contracts
August 28, 2023
Respiri completes acquisition of Access Managed Services
August 13, 2023
Completion of private placement
August 11, 2023
SPP strongly supported raising $3m
August 8, 2023
Access Telehealth acquisition presentation
June 6, 2023
RSH acquires US based Access RPM, capital raise and new NED
May 23, 2023
Half Yearly Report and Accounts
February 27, 2023
Successful close of Share Purchase Plan
February 13, 2023
RPM successfully reimbursed and claimed by physicians
February 5, 2023
Security Purchase Plan extension of closing date
January 24, 2023
Nth Carolina hospital commence wheezo RPM patient onboarding
January 8, 2023
Security Purchase Plan
December 27, 2022
Arkansas Heart Hospital commences patients on wheezo RPM
December 22, 2022
wheezo RPM program expands into New Mexico USA
December 15, 2022
First patients selected and enrolled into Minnesota Lung Ctr
December 13, 2022
First primary care practice secured and first patients
December 6, 2022
wheezo RPM program selected by leading USA heart center
November 27, 2022
Minnesota Lung Centre select wheezo and RMP for pilot prog.
November 17, 2022
Chairman and CEOs Presentation to Shareholders
November 14, 2022
Key milestone - First patients enrol into wheezo RPM program
November 6, 2022
Centre of Digital Innovation Excellence established
September 27, 2022
Placement of $1.6m to Support US Expansion
September 21, 2022
Investor USA market update and presentation
August 17, 2022
Monthly Activities/Appendix 4C Cash Flow Report
July 29, 2022
Wheezo successfully integrated in Michigan Children Hospital
July 28, 2022
Investor presentation
July 15, 2022
New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
July 11, 2022
Reinstatement to Quotation
May 2, 2022
Completion of Placement
May 2, 2022
RPM pilot program at Childrens Hospital of Michigan
March 14, 2022
Second RPM Agreement with Access TeleHealth
February 6, 2022
Respiri secures a second order from mTeleHealth
February 3, 2022
Respiri enters Distribution/Marketing Agreement in USA
December 22, 2021
Clarification Announcement
July 4, 2021
Webinar presentation - Investor Update
June 23, 2021
Pharmacy Network to Commence Sales of wheezo
June 22, 2021
Trading Update
June 14, 2021
Appendix 4C - quarterly
April 29, 2021
Respiri Partnership with TerryWhite Chemmart Group
April 27, 2021
Investor Presentation
March 22, 2021
Half Year Accounts
February 19, 2021
Company Update Post Commercial Launch
December 8, 2020
Manufacturing update
November 3, 2020
Decks
The 5 newest of 15 decks. Every deck is listed under its year.
- Corporate Update (October 2026)
Corporate update · 21 slides · Oct 6, 2026
- Investor Presentation (June 2026)
Investor deck · 27 slides · Jun 11, 2026
- Investor Presentation (March 2026)
Investor deck · 16 slides · Mar 19, 2026
- Investor Presentation (July 2025)
Investor deck · 31 slides · Jul 2, 2025
- Investor Presentation (June 2025)
Investor deck · 20 slides · Jun 2, 2025